McKesson

McKesson
McKesson
MCK
NYSE
640.74 USD
0.01%

About

McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States.

Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies.

Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada..

Financials Amount (in millions)

Income statement
Balance sheet
Cash flow

Ratios

Price and Volume
Volume
Ten Day Average Volume 653.4K
Three Month Average Volume 16.2M
High Low
Fifty-Two Week High 637.51 USD
Fifty-Two Week Low 404.72 USD
Fifty-Two Week High Date 02 Aug 2024
Fifty-Two Week Low Date 05 Sep 2023
Price and Volume
Current Price 561.08 USD
Beta 0
Relative Price Change
Four Week Relative Price Change -15.75%
Thirteen Week Relative Price Change -7.96%
Twenty-Six Week Relative Price Change -2.96%
Fifty-Two Week Relative Price Change 8.60%
Year-to-Date Relative Price Change 2.34%
Price Change
One Day Price Change 0.89%
Thirteen Week Price Change -1.49%
Twenty-Six Week Price Change 6.69%
Five Day Price Change 1.62%
Fifty-Two Week Price Change 36.08%
Year-to-Date Price Change 21.19%
Month-to-Date Price Change -9.07%
Per Share Data
Book Value
Book Value Per Share (Last Fiscal Year) -15.16154 USD
Book Value Per Share (Most Recent Quarter) -13.53365 USD
Tangible Book Value Per Share (Last Fiscal Year) -109.3308 USD
Tangible Book Value Per Share (Most Recent Quarter) -107.3284 USD
EBITD
EBITD Per Share (Trailing Twelve Months) 34.67672 USD
Revenue
Revenue Per Share (Last Fiscal Year) 2303.885 USD
Revenue Per Share (Trailing Twelve Months) 2365.7 USD
Dividend
Dividend Per Share (Last Fiscal Year) 2.32 USD
Dividend Per Share (Trailing Twelve Months) 2.4 USD
Dividend Per Share (5 Year) 1.876 USD
Earnings Per Share
Excluding Extraordinary Items (Last Fiscal Year) 22.38628 USD
Excluding Extraordinary Items (Trailing Twelve Months) 22.35126 USD
Normalized (Last Fiscal Year) 22.44225 USD
Basic Excluding Extraordinary Items (Last Fiscal Year) 22.53754 USD
Basic Excluding Extraordinary Items (Trailing Twelve Months) 22.49352 USD
Including Extraordinary Items (Last Fiscal Year) 22.38628 USD
Including Extraordinary Items (Trailing Twelve Months) 22.35126 USD
Cash
Cash Per Share (Last Fiscal Year) 35.25385 USD
Cash Per Share (Most Recent Quarter) 17.75183 USD
Cash Flow Per Share (Last Fiscal Year) 28.49366 USD
Cash Flow Per Share (Trailing Twelve Months) 28.41093 USD
Free Cash Flow Per Share (Trailing Twelve Months) 22.12253 USD
Margins
Cash Flow Revenue
Cash Flow Revenue (5 Year) 1
Cash Flow Revenue (Trailing Twelve Months) 1
Pretax Margin
Pretax Margin (Trailing Twelve Months) 1.21%
Pretax Margin (Last Fiscal Year) 1.23%
Pretax Margin (5 Year) 0.49%
Gross Margin
Gross Margin (Last Fiscal Year) 4.07%
Gross Margin (Trailing Twelve Months) 4.06%
Gross Margin (5 Year) 4.74%
Operating Margin
Operating Margin (Last Fiscal Year) 1.27%
Operating Margin (Trailing Twelve Months) 1.23%
Operating Margin (5 Year) 0.61%
Net Profit Margin
Net Profit Margin (Last Fiscal Year) 1.02%
Net Profit Margin (Trailing Twelve Months) 1.00%
Net Profit Margin (5 Year) 0.38%
Growth
Book Value
Book Value Per Share (5 Year) -99,999.99%
Tangible Book Value (5 Year) -99,999.99%
Free Operating Cash Flow
Free Operating Cash Flow (5 Year) 0.78%
Revenue
Revenue Change MRQ vs 1 Year Ago 6.44%
Revenue Growth (3 Year) 7.59%
Revenue Change (Trailing Twelve Months) 10.46%
Revenue Per Share Growth 16.19%
Revenue Growth (5 Year) 9.05%
Capital Spending Debt
Capital Spending (5 Year) 4.28%
Total Debt (5 Year) -5.82%
Dividends
Dividend Growth (3 Year) 11.80%
Earnings Per Share
EPS Change MRQ vs 1 Year Ago -0.18%
EPS Change (Trailing Twelve Months) -16.73%
EPS Growth (3 Year) -99,999.99%
EPS Growth (5 Year) -99,999.99%
EBITDA
EBITDA (5 Year) 2.05%
EBITDA (5 Year Interim) 2.25%
Net Profit Margin
Net Profit Margin Growth (5 Year) 67.15%
Valuation
Total Price to Book
Price to Tangible Book (Last Fiscal Year) -100,000
Price to Tangible Book (Most Recent Quarter) -100,000
Price to Free Cash Flow
Price to Free Cash Per Share (Last Fiscal Year) 22
Price to Free Cash Per Share (Trailing Twelve Months) 25
Net Debt
Net Debt (Most Recent Quarter) 3.3B
Net Debt (Last Fiscal Year) 1.0B
Price to Sales
Price to Sales (Last Fiscal Year) 0
Price to Sales (Trailing Twelve Months) 0
Price to Earnings
PE Excluding Extraordinary Items (Last Fiscal Year) 25
PE Normalized (Last Fiscal Year) 25
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) 26
PE Excluding Extraordinary Items High (Trailing Twelve Months) 42
PE Excluding Extraordinary Items Low (Trailing Twelve Months) 11
PE Including Extraordinary Items (Trailing Twelve Months) 25
Dividends
Dividend Yield (5 Year) 0.61%
Dividend Yield 0.51%
Current Dividend Yield 0.43%
Price to Book
Price to Book (Last Fiscal Year) -100,000
Price to Book (Most Recent Quarter) -100,000
Financial Strength
Debt to Equity
Long Term Debt to Equity (Last Fiscal Year) -100,000
Long Term Debt to Equity (Most Recent Quarter) -100,000
Payout Ratio
Payout Ratio (Last Fiscal Year) 10.66%
Payout Ratio (Trailing Twelve Months) 11.15%
Quick Ratio
Quick Ratio (Last Fiscal Year) 1
Quick Ratio (Most Recent Quarter) 0
Enterprise Value
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) 26
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) 28
Current Ratio
Current Ratio (Last Fiscal Year) 1
Current Ratio (Most Recent Quarter) 1
Free Cash Flow
Free Cash Flow (Last Fiscal Year) 3.3B
Free Cash Flow (Trailing Twelve Months) 2.9B
Net Interest Coverage
Net Interest Coverage (Last Fiscal Year) 26
Net Interest Coverage (Trailing Twelve Months) 14
Total Debt to Equity
Total Debt to Equity (Last Fiscal Year) -100,000
Total Debt to Equity (Most Recent Quarter) -100,000
Management Effectiveness
Return on Assets
Return on Assets (Last Fiscal Year) 4.87%
Return on Assets (Trailing Twelve Months) 4.60%
Return on Assets (5 Year) 1.57%
Return on Equity
Return on Equity (Last Fiscal Year) -99,999.99%
Return on Equity (Trailing Twelve Months) -99,999.99%
Return on Equity (5 Year) 101.21%
Return on Investment
Return on Investment (Last Fiscal Year) 22.01%
Return on Investment (Trailing Twelve Months) 20.70%
Return on Investment (5 Year) 6.03%

Cookie Settings

We use cookies to deliver and improve our services, analyze site usage, and if you agree, to customize or personalize your experience and market our services to you. You can read our Cookie Policy here.